MBCOF (Marvel Biosciences) Long-Term Debt: $0.45 Mil (As of Apr. 2026)


MBCOF Marvel Biosciences Corp MBCOF
34 GF Score
Price $0.11
! 1 Warning Sign
View Full Analysis

What is Marvel Biosciences Long-Term Debt?

Marvel Biosciences MBCOF 34 Long-Term Debt is $0.45 Mil as of Apr. 2026. GuruFocus rates MBCOF with a GF Score™ of 34/100. The stock has 1 warning sign investors should review.

Marvel Biosciences's Long-Term Debt for the quarter that ended in Apr. 2026 was $0.45 Mil.

Marvel Biosciences's quarterly Long-Term Debt stayed the same from Oct. 2025 ($0.00 Mil) to Jan. 2026 ($0.00 Mil) but then increased from Jan. 2026 ($0.00 Mil) to Apr. 2026 ($0.45 Mil).

Marvel Biosciences's annual Long-Term Debt declined from Jul. 2023 ($0.76 Mil) to Jul. 2024 ($0.00 Mil) but then stayed the same from Jul. 2024 ($0.00 Mil) to Jul. 2025 ($0.00 Mil).

Marvel Biosciences  (OTCPK:MBCOF) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Marvel Biosciences Long-Term Debt Related Terms

Marvel Biosciences Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Marvel Biosciences's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Marvel Biosciences Long-Term Debt Chart

Marvel Biosciences Annual Data
Trend Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
Long-Term Debt
Get a 7-Day Free Trial 0.00 0.00 0.76 0.00 0.00

Marvel Biosciences Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.51 0.00 0.00 0.00 0.45
MBCOF
34GF Score
Marvel Biosciences Corp MBCOF
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of $0.45 Mil mean?
Marvel Biosciences (MBCOF) has a Long-Term Debt of $0.45 Mil as of Apr. 2026.
Is Marvel Biosciences' Long-Term Debt too high?
Marvel Biosciences' current Long-Term Debt is $0.45 Mil. Overall, Marvel Biosciences has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Marvel Biosciences' Long-Term Debt compare to VRTX and REGN?
Marvel Biosciences' Long-Term Debt of $0.45 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Biotechnology company?
A good Long-Term Debt depends on the Biotechnology industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Marvel Biosciences's current Long-Term Debt is $0.45 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Marvel Biosciences stock overvalued right now?
Marvel Biosciences (MBCOF) has a current Long-Term Debt of $0.45 Mil. The current Long-Term Debt is $0.45 Mil. Marvel Biosciences' overall GF Score™ is 34/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Marvel Biosciences (MBCOF), the current Long-Term Debt is $0.45 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Marvel Biosciences Business Description

Other Exchanges MRVL:Canada
Address 505 - 8th Avenue SW, Suite 420, Calgary, AB, CAN, T2P1G2
Marvel Biosciences Corp is a biotechnology company incorporated in Canada. The Company is currently a pre-clinical stage pharmaceutical development company that utilizes a drug redevelopment approach to identify and evaluate potential therapeutic compounds. Its activities mainly involve scientific research and pre-clinical studies aimed at determining viable active compounds for further drug development.
34GF Score

Get the complete analysis for MBCOF

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.11
Price